medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2021, Number 3

<< Back Next >>

Rev Nefrol Dial Traspl 2021; 41 (3)

Crescentic glomerulonephritis associated with levamisoleadulterated cocaine. A case report and a review of the literature

Gómez-Calcetero C, Castro-Castillo LP, Salazar-Reggeti R, Aivasovsky-Trotta I, Celis LG

Language: Spanish
References: 29
Page: 207-213
PDF size: 154.63 Kb.


ABSTRACT

Introduction: Levamisole is an anthelmintic drug, also known for its use as an immunomodulator which, because of its toxic effects, was withdrawn at the end of the 20th century. In 2005, because of an increase in the diagnosis of pauci-immune vasculitis among the population that uses psychoactive substances, the adulteration of cocaine for commercial purposes by combining it with levamisole was documented. Case Report: The case of a young adult with a history of Alport Syndrome and recent consumption of psychoactive substances is presented. A renal biopsy is performed, demonstrating the presence of pauci-immune crescentic glomerulonephritis. Therefore, this type of small vessel vasculitis with kidney involvement and immune complex deposition was associated with the use of cocaine adulterated with levamisole. Discussion: Levamisole, a drug approved by the FDA in 1991, acts as an immunomodulator, antiparasitic and adjuvant in chemotherapy. Levamisole produces a rheumatic syndrome characterized by the presence of glomerulonephritis, alveolar hemorrhage, retinal purpura, neutropenia, and agranulocytosis in association with the presence of anti-neutrophil cytoplasmic antibodies. Conclusion: levamisole is known for its anthelmintic and immunomodulatory properties, additionally it can produce ostensible toxic effects. Given the high consumption of cocaine among the indigent population, the presence of this adulterant constitutes a growing public health problem.


REFERENCES

  1. Amery WK, Bruynseels JP. Levamisole, the story andthe lessons. Int J Immunopharmacol. 1992;14(3):481-6.doi: 10.1016/0192-0561(92)90179-o.

  2. Larocque A, Hoffman RS. Levamisole in cocaine:unexpected news from an old acquaintance. ClinToxicol. 2012;50(4):231-41. doi: 10.3109/15563650.2012.665455.

  3. Kudlacek O, Hofmaier T, Luf A, Mayer FP, StocknerT, Nagy C, et al. Cocaine adulteration. J ChemNeuroanat. 2017;83-84:75-81. doi: 10.1016/j.jchemneu.2017.06.001.

  4. 2020 World Drug Report. Drug use and healthconsequences. Vienna: report, 2020. 49 p.

  5. Chang A, Osterloh J, Thomas J. Levamisole: adangerous new cocaine adulterant. Clin PharmacolTher. 2010;88(3):408-11. doi: 10.1038/clpt.2010.156.

  6. George TC, Freet DJ, Cross JM, Huzar TF. Levamisoleinducedvasculitis. JAAPA. 2019;32(1):23-7. doi:10.1097/01.JAA.0000547746.08181.f7.

  7. Moinuddin I, Madhrira M, Bracamonte E, ThajudeenB, Sussman A. Membranous nephropathy withcrescents associated with levamisole-induced MPOANCAvasculitis. Pathol Res Pract. 2016;212(7):650-3.doi: 10.1016/j.prp.2016.03.008.

  8. Karch SB, Mari F, Bartolini V, Bertol E. Aminorexpoisoning in cocaine abusers. Int J Cardiol.2012;158(3):344-6. doi: 10.1016/j.ijcard.2011.06.105.

  9. Kumar D, Batal I, Jim B, Mendez B, Anis K. Unusualcase of levamisole-induced dual-positive ANCAvasculitis and crescentic glomerulonephritis. BMJ CaseRep. 2018;2018:bcr2018225913. doi: 10.1136/bcr-2018-225913.

  10. Collister D, Sathianathan C, Ryz K, Karpinski M,Bernstein K, Gibson IW. ANCA associated vasculitissecondary to levamisole-adultered cocaine withassociated membranous nephropathy: a case series. Am JNephrol. 2017;45(3):209-16. doi: 10.1159/000456553.

  11. Dherange PA, Beatty N, Al-Khashman A. Levamisoleadulteratedcocaine: a case of retiform purpura,cutaneous necrosis and neutropenia. BMJ Case Rep.2015;2015:bcr2015211768. doi: 10.1136/bcr-2015-211768.

  12. Miner J, Gruber P, Perry TL. Early excision and grafting,an alternative approach to the surgical management oflarge body surface area levamisole-adulterated cocaineinduced skin necrosis. Burns. 2015;41(3):e34-40. doi:10.1016/j.burns.2014.10.032.

  13. Kopp SA, High WA, Green JJ. Levamisole-inducedWegener’s granulomatosis following contaminatedcocaine abuse. Skinmed. 2012;10(4):254-6.

  14. Gulati S, Donato AA. Lupus anticoagulant and ANCAassociated thrombotic vasculopathy due to cocainecontaminated with levamisole: a case report and reviewof the literature. J Thromb Thrombolysis. 2012;34(1):7-10. doi: 10.1007/s11239-012-0711-0.

  15. Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM.Five consecutive cases of a cutaneous vasculopathyin users of levamisole-adulterated cocaine. J ClinRheumatol. 2011;17(4):193-6. doi: 10.1097/RHU.0b013e31820e6822.

  16. Walsh NM, Green PJ, Burlingame RW, Pasternak S,Hanly JG. Cocaine-related retiform purpura: evidenceto incriminate the adulterant, levamisole. J CutanPathol. 2010;37(12):1212-9. doi: 10.1111/j.1600-0560.2010.01613.x.

  17. Khan TA, Cuchacovich R, Espinoza LR, Lata S,Patel NJ, Garcia-Valladares I, et al. Vasculopathy,hematological, and immune abnormalities associatedwith levamisole-contaminated cocaine use. SeminArthritis Rheum. 2011;41(3):445-54. doi: 10.1016/j.semarthrit.2011.04.010.

  18. Graf J, Lynch K, Yeh CL, Tarter L, Richman N,Nguyen T, et al. Purpura, cutaneous necrosis, andantineutrophil cytoplasmic antibodies associatedwith levamisole-adulterated cocaine. Arthritis Rheum.2011;63(12):3998-4001. doi: 10.1002/art.30590.

  19. Poon SH, Baliog CR Jr, Sams RN, Robinson-Bostom L, Telang GH, Reginato AM. Syndromeof cocaine-levamisole-induced cutaneous vasculitisand immune-mediated leukopenia. Semin ArthritisRheum. 2011;41(3):434-44. doi: 10.1016/j.semarthrit.2011.05.009.

  20. Veronese FV, Dode RS, Friderichs M, Thomé GG,da Silva DR, Schaefer PG, et al. Cocaine/levamisoleinducedsystemic vasculitis with retiform purpuraand pauci-immune glomerulonephritis. Braz J MedBiol Res. 2016;49(5):e5244. doi: 10.1590/1414-431X20165244.

  21. Friedman DR, Wolfsthal SD. Cocaine-inducedpseudovasculitis. Mayo Clin Proc. 2005;80(5):671-3.doi: 10.4065/80.5.671.

  22. Nolan AL, Jen KY. Pathologic manifestations oflevamisole-adulterated cocaine exposure. Diagn Pathol.2015;10:48. doi: 10.1186/s13000-015-0279-z.

  23. Czuchlewski DR, Brackney M, Ewers C, Manna J,Fekrazad MH, Martinez A, et al. Clinicopathologicfeatures of agranulocytosis in the setting of levamisoletaintedcocaine. Am J Clin Pathol. 2010;133(3):466-72.doi: 10.1309/AJCPOPQNBP5THKP1.

  24. McGrath MM, Isakova T, Rennke HG, Mottola AM,Laliberte KA, Niles JL. Contaminated cocaine andantineutrophil cytoplasmic antibody-associated disease.Clin J Am Soc Nephrol. 2011;6(12):2799-805. doi:10.2215/CJN.03440411.

  25. Carrara C, Emili S, Lin M, Alpers CE. Necrotizingand crescentic glomerulonephritis with membranousnephropathy in a patient exposed to levamisoleadulteratedcocaine. Clin Kidney J. 2016;9(2):234-8.doi: 10.1093/ckj/sfv141.

  26. Roca-Argente L, Moll-Guillen JL, Espí-Reig J, Blanes-Julia M, García-Martínez AM, Pujol-Marco C, et al.Membranous glomerulonephritis and cellular crescentsinduced by levamisole-adulterated cocaine abuse: acase report. Ann Transl Med. 2015;3(18):271. doi:10.3978/j.issn.2305-5839.2015.10.29.

  27. Carlson AQ, Tuot DS, Jen KY, Butcher B, Graf J,Sam R, et al. Pauci-immune glomerulonephritis inindividuals with disease associated with levamisoleadulteratedcocaine: a series of 4 cases. Medicine(Baltimore). 2014;93(17):290-7. doi: 10.1097/MD.0000000000000090.

  28. Munoz CH, Vanegas AL, Arbelaez A, Restrepo M,Vasquez GM, Correa LA, et al. FRI0366 cocainelevamisoleinduced vasculitis: a series of 11 cases. AnnRheum Dis. 2016;75(Suppl. 2):567. doi: 10.1136/annrheumdis-2016-eular.2477.

  29. Geetha D, Jefferson JA. ANCA-associated vasculitis:core curriculum 2020. Am J Kidney Dis. 2020;75(1):124-37. doi: 10.1053/j.ajkd.2019.04.031.




2020     |     www.medigraphic.com